Matrix OI® FLEX IT
Providing the next generation
of regenerative therapies.
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
Matrix OI® FLEX IT
Matrix OI® FlexIT, when hydrated, is a thin pliable cortical sheet that has the ability to be sized with scissors or a scalpel.
Matrix OI® products are verified for osteoinductivity prior to release for distribution. In-vivo Matrix OI® test results demonstrate all five (5) bone-forming elements present (Chondrocytes, Osteocytes, Bone Marrow, Cartilage, and New Bone). In-vitro Matrix OI® test results for BMP levels demonstrate CellRight’s Matrix OI® products have up to 19x the native BMP levels of the BMP-2 control.
The grafts are freeze-dried and sterilized using low-dose gamma irradiation to achieve a sterility assurance level (SAL) of 10-6. The grafts should be stored in ambient temperatures (59-86o F or 15-30o C) and have a shelf life of five-years from the date of packaging.
CellRight’s proprietary next-generation BioRinseTM processing technology has been proven to preserve native bone morphogenic proteins (BMP’s).
Matrix OI® FlexIT is indicated for homologous use in craniomaxillofacial applications including cranial repair, orbital floor, and zygomatic fractures, involving sutures, plates, anchors, and other fixation devices. Other uses for Matrix OI® FlexIT include reconstruction, posterolateral spinal procedures, long-bone fracture plate, non-unions, and dental procedures.
Features and Benefits
- 100% bone
- Osteoinductive – each lot is in-vivo tested
- Osteoconductive
- Aseptically processed
- Sterile – sterility assurance level of 10-6
- Five-year shelf life
- Ambient storage and shipping temperatures
- Resists migration
- Available in multiple geometries and sizes
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”